Feb 17, 2010
By:
Chitra Sethi
Merck & Co. (Whitehouse Station, NJ) has announced restructuring plans that include reducing its companywide workforce by 15% by the end of 2012.
|
Feb 12, 2010
By:
Chitra Sethi
Novavax will discontinue negotiations for the previously announced collaboration with Madrid-based ROVI Pharmaceuticals.
|
Feb 4, 2010
By:
Chitra Sethi
Watson Pharmaceuticals has acquired Eden Biodesign for $15 million.
|
Jan 29, 2010
By:
Chitra Sethi
London-based pharmaceutical company AstraZeneca plans to slash 8,000 jobs, or 12% of its work force, by 2014 to cut costs.
|
Jan 15, 2010
By:
Chitra Sethi
The results of BioPharm International's fourth annual salary survey, conducted in the fall of 2009, shows that women lag behind their male counterparts.
|
Jan 8, 2010
By:
Chitra Sethi
Genzyme (Cambridge, MA) will outsource fill-and-finish operations for its drugs Cerezyme, Fabrazyme, Myozyme, and Thyrogen to Illinois-based Hospira, Inc.
|
The year 2009 was marked by recession, industry megamergers, and venture-capital scarcity. How did biopharmaceutical professionals fare?
Jan 1, 2010
By:
Chitra Sethi
The year 2009 was marked by recession, industry megamergers, and venture-capital scarcity. How did biopharmaceutical professionals fare?
|
Dec 16, 2009
By:
Chitra Sethi
Sanofi Pasteur, the vaccines division of France-based Sanofi-Aventis Group, is voluntarily recalling about 800,000 doses of H1N1 (swine) flu vaccine meant for children between the ages of 6 months and 35 months because quality assurance tests indicate the vaccine doses lost some potency.
|
Nov 30, 2009
By:
Chitra Sethi
The US Food and Drug Administration has approved Agriflu, a new seasonal flu vaccine manufactured by Novartis Vaccines and Diagnostics (Siena, Italy), for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.
|
|
